Holen Sie sich die Stockscreener-App
7.04
1.88%
0.13
Handel nachbörslich:
6.81
-0.23
-3.27%
Schlusskurs vom Vortag:
$6.91
Offen:
$6.9
24-Stunden-Volumen:
644.67K
Relative Volume:
0.51
Marktkapitalisierung:
$456.33M
Einnahmen:
$202.09M
Nettoeinkommen (Verlust:
$-61.69M
KGV:
-6.5185
EPS:
-1.08
Netto-Cashflow:
$-35.64M
1W Leistung:
+2.77%
1M Leistung:
-3.56%
6M Leistung:
-30.84%
1J Leistung:
-39.21%
1-Tages-Spanne:
$6.84
$7.05
1-Wochen-Bereich:
$6.80
$7.285
52-Wochen-Spanne:
$5.71
$17.12
Evolus Inc Stock (EOLS) Company Profile
Firmenname
Evolus Inc
Sektor
Telefon
(949) 284-4555
Adresse
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Vergleichen Sie EOLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
7.04 | 447.90M | 202.09M | -61.69M | -35.64M | -1.08 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Herabstufung | Needham | Buy → Hold |
| 2025-04-17 | Eingeleitet | BTIG Research | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-06-23 | Eingeleitet | Needham | Buy |
| 2022-05-12 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-20 | Hochstufung | Truist | Hold → Buy |
| 2021-05-06 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-04-08 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-24 | Herabstufung | Truist | Buy → Hold |
| 2020-07-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-02-06 | Fortgesetzt | Mizuho | Buy |
| 2019-11-26 | Eingeleitet | SVB Leerink | Outperform |
| 2019-09-05 | Fortgesetzt | Mizuho | Buy |
| 2019-06-28 | Eingeleitet | Wells Fargo | Market Perform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-02-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-29 | Eingeleitet | Stifel | Buy |
Alle ansehen
Evolus Inc Aktie (EOLS) Neueste Nachrichten
Mizuho reaffirms Evolus stock rating at Outperform amid early signs of market stabilization - Investing.com Canada
Evolus Navigates a Path to Profitability Amidst Quarterly Challenges - Ad-hoc-news.de
(EOLS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Midday Stock Roundup: Compass Diversified Falls 20% After Conference Call - Orange County Business Journal
Stonepine Capital Management LLC Has $8.44 Million Holdings in Evolus, Inc. $EOLS - MarketBeat
How Evolus Inc. (EVL) stock compares with tech leadersWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Mizuho lowers Evolus stock price target on consumer sentiment concerns By Investing.com - Investing.com Canada
Why Evolus Inc. stock attracts global investorsJuly 2025 Volume & Community Consensus Picks - Newser
Mizuho lowers Evolus stock price target on consumer sentiment concerns - Investing.com India
Is Evolus Inc. stock a defensive play in 2025July 2025 Recap & Technical Pattern Based Buy Signals - Newser
How Evolus Inc. (EVL) stock behaves in tightening cyclesJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser
How cyclical is Evolus Inc. (EVL) stock compared to rivalsEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
How Evolus Inc. (EVL) stock reacts to stronger dollarQuarterly Market Review & Verified Entry Point Signals - Newser
Will Evolus Inc. (EVL) stock beat Nasdaq index returnsEarnings Growth Summary & Accurate Entry/Exit Alerts - Newser
H.C. Wainwright reiterates Buy rating on Evolus stock with $20 price target By Investing.com - Investing.com South Africa
Mizuho Maintains Evolus (EOLS) Outperform Recommendation - Nasdaq
H.C. Wainwright reiterates Buy rating on Evolus stock with $20 price target - Investing.com Nigeria
Analyst Mizuho Lowers Price Target for Evolus (EOLS) to $19.00 | EOLS Stock News - GuruFocus
Evolus price target lowered to $19 from $20 at Mizuho - TipRanks
Is Evolus Inc. (EVL) stock a fit for income portfoliosJuly 2025 WrapUp & AI Enhanced Trading Alerts - Newser
How Evolus Inc. (EVL) stock expands through international marketsShort Setup & Advanced Technical Analysis Signals - Newser
Mizuho lowers Evolus stock price target to $19 on consumer sentiment concerns - Investing.com Canada
Can Evolus Inc. stock deliver strong Q4 earningsMarket Growth Review & Daily Stock Momentum Reports - BỘ NỘI VỤ
Price-Driven Insight from (EOLS) for Rule-Based Strategy - news.stocktradersdaily.com
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability - Yahoo Finance
Midday Stock Roundup: LoanDepot Falls After Top Executive Sells Shares - Orange County Business Journal
Evolus, Inc. (NASDAQ:EOLS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Will Evolus Inc. (EVL) stock announce a stock split2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
Is Evolus Inc. (EVL) stock considered safe havenJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Will Evolus Inc. stock see insider buyingJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - newser.com
Is Evolus Inc. stock trading near support levels2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Finanzdaten der Evolus Inc-Aktie (EOLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):